Ridhwi Mukerji - Concepedia

Author

Ridhwi Mukerji

University of Kansas Medical Center

Also Known As

R. Mukerji, R.S. Mukerji, Ridhwi Mukerji

Publications

596

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center University of Kansas

About

Ridhwi Mukerji is an author at University of Kansas Medical Center specializing in medicine, oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	251
2	Pharmacology	4	4	198
3	Pathology	3	3	154
4	Cancer Therapeutics	3	3	154
5	Cell Biology	1	1	53

Ridhwi Mukerji

Publications

518

Citations

H-Index

Page 1

	Year	Citations
Withaferin A, a Cytotoxic Steroid from <i>Vassobia breviflora</i>, Induces Apoptosis in Human Head and Neck Squamous Cell Carcinoma Abbas Samadi, Xiaoqin Tong, Ridhwi Mukerji, Journal of Natural Products	2010	83
Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells Xuan Zhang, Ridhwi Mukerji, Abbas Samadi, BMC Complementary and Alternative Medicine	2011	80
Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation Abbas Samadi, Stephanie M. Cohen, Ridhwi Mukerji, Tumor Biology	2012	71
A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers Stephanie M. Cohen, Ridhwi Mukerji, Barbara N. Timmermann, The American Journal of Surgery Withaferin AAnaplastic Thyroid CancersMedicineThyroid DiseasePharmacology	2012	66
A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo Abbas Samadi, Ridhwi Mukerji, Anuj Shah, Surgery OncologyMedicineThyroid DiseaseMedullary Thyroid CancerPathology	2010	59
A novel C-terminal HSP90 inhibitor KU135 induces apoptosis and cell cycle arrest in melanoma cells Abbas Samadi, Xuan Zhang, Ridhwi Mukerji, Cancer Letters Cancer ResearchCell RegulationMedicineApoptosisMelanoma	2011	53
Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo Stephanie M. Cohen, Ridhwi Mukerji, Shuang Cai, The American Journal of Surgery NanomedicineSubcutaneous DeliveryAdvanced Breast CancerOncologyDrug Targeting	2011	44
Efficacy and Toxicity of Peritumoral Delivery of Nanoconjugated Cisplatin in an In Vivo Murine Model of Head and Neck Squamous Cell Carcinoma Stephanie M. Cohen, Nick Rockefeller, Ridhwi Mukerji, JAMA Otolaryngology–Head & Neck Surgery	2013	33
Novel C-Terminal Hsp90 Inhibitor for Head and Neck Squamous Cell Cancer (HNSCC) with in vivo Efficacy and Improved Toxicity Profiles Compared with Standard Agents Stephanie M. Cohen, Ridhwi Mukerji, Abbas Samadi, Annals of Surgical Oncology OncologyMedicineTreatment ResistanceStandard AgentsPathology	2011	29

Page 1